+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Radiopharmaceuticals Market Research Report by Application, by Procedural Volume, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4829949
  • Report
  • July 2021
  • Region: Global
  • 189 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Radiopharmaceuticals Market will Grow to USD 6,208.64 Million by 2026, at a CAGR of 6.25%

FEATURED COMPANIES

  • Alliance Medical
  • Bracco Imaging SpA
  • Clarity Pharmaceuticals
  • Eckert & Ziegler
  • GE Healthcare Inc
  • Medtronic PLC
  • MORE
The Global Radiopharmaceuticals Market size was estimated at USD 4,314.59 Million in 2020 and expected to reach USD 4,569.80 Million in 2021, at a Compound Annual Growth Rate (CAGR) 6.25% to reach USD 6,208.64 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Radiopharmaceuticals to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Application, the Radiopharmaceuticals Market was studied across Diagnostic Applications and Therapeutic Applications. The Diagnostic Applications is further studied across Pet Applications and Spect Applications. The Therapeutic Applications is further studied across Bone Metastasis, Endocrine Tumors, Lymphoma, and Thyroid.
  • Based on Type, the Radiopharmaceuticals Market was studied across Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine. The Diagnostic Nuclear Medicine is further studied across Pet Radiopharmaceuticals and Spect Radiopharmaceuticals. The Therapeutic Nuclear Medicine is further studied across Alpha Emitters, Beta Emitters, and Brachytherapy Isotopes.
  • Based on Procedural Volume, the Radiopharmaceuticals Market was studied across Diagnostic Procedures and Therapeutic Procedures. The Diagnostic Procedures is further studied across Pet Radiopharmaceuticals and Spect Radiopharmaceuticals. The Therapeutic Procedures is further studied across Alpha Emitters, Beta Emitters, and Brachytherapy Isotopes.
  • Based on Region, the Radiopharmaceuticals Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Radiopharmaceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Radiopharmaceuticals Market, including Advanced Accelerator Applications S.A, Alliance Medical, Bayer AG, Bracco Imaging SpA, Cardinal Health, Inc., Clarity Pharmaceuticals, Curium France SASU, Eckert & Ziegler, Eczacibasi-Monrol Nuclear Products Co., Fusion Pharma, GE Healthcare Inc, Global Medical Solutions, LTD., Institute of Isotopes Co., LTD., IsoTherapeutics Group, LLC, Isotopia Molecular Imaging Limited, Joint Stock Company Isotope, Jubilant Pharma Holdings Inc., Lantheus Medical Imaging, Inc., Mallinckrodt PLC, Medtronic PLC, Navidea Biopharmaceuticals, Inc., Nordion, Inc., Northstar Medical Radioisotopes, LLC, NTP Radioisotopes Soc, LTD., Pharmalogic, Shine Medical Technologies, Siemens Healthineers AG, Sigma- Aldrich Corporation, and Sinotau Pharmaceuticals Group.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Radiopharmaceuticals Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Radiopharmaceuticals Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Radiopharmaceuticals Market?
4. What is the competitive strategic window for opportunities in the Global Radiopharmaceuticals Market?
5. What are the technology trends and regulatory frameworks in the Global Radiopharmaceuticals Market?
6. What is the market share of the leading vendors in the Global Radiopharmaceuticals Market?
7. What modes and strategic moves are considered suitable for entering the Global Radiopharmaceuticals Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alliance Medical
  • Bracco Imaging SpA
  • Clarity Pharmaceuticals
  • Eckert & Ziegler
  • GE Healthcare Inc
  • Medtronic PLC
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. Procedural Volume Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence and prevalence of target conditions
5.1.1.2. Alpha radioimmunotherapy-based targeted cancer treatment
5.1.1.3. Initiatives to reduce the demand-supply gap of mo-99
5.1.2. Restraints
5.1.2.1. Shorter life of radiopharmaceuticals
5.1.3. Opportunities
5.1.3.1. Adoption of radiopharmaceuticals in neurological applications
5.1.4. Challenges
5.1.4.1. High equipment prices lead to reduced hospital budget
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Radiopharmaceuticals Market, by Application
6.1. Introduction
6.2. Diagnostic Applications
6.2.1. Pet Applications
6.2.1.1. Cardiology
6.2.1.2. Neurology
6.2.1.3. Oncology
6.2.2. Spect Applications
6.2.2.1. Cardiology
6.2.2.2. Lymphoma
6.2.2.3. Neurology
6.2.2.4. Thyroid
6.3. Therapeutic Applications
6.3.1. Bone Metastasis
6.3.2. Endocrine Tumors
6.3.3. Lymphoma
6.3.4. Thyroid

7. Radiopharmaceuticals Market, by Type
7.1. Introduction
7.2. Diagnostic Nuclear Medicine
7.2.1. Pet Radiopharmaceuticals
7.2.1.1. F-18
7.2.1.2. Ru-82
7.2.2. Spect Radiopharmaceuticals
7.2.2.1. Ga-67
7.2.2.2. I-123
7.2.2.3. Tc-99m
7.2.2.4. Tl-201
7.3. Therapeutic Nuclear Medicine
7.3.1. Alpha Emitters
7.3.1.1. Ra-223
7.3.2. Beta Emitters
7.3.2.1. I-131
7.3.2.2. Lu-177
7.3.2.3. Re-186
7.3.2.4. Sm-153
7.3.2.5. Y-90
7.3.3. Brachytherapy Isotopes
7.3.3.1. Cs-131
7.3.3.2. I-125
7.3.3.3. Ir-192
7.3.3.4. Pd-103

8. Radiopharmaceuticals Market, by Procedural Volume
8.1. Introduction
8.2. Diagnostic Procedures
8.2.1. Pet Radiopharmaceuticals
8.2.2. Spect Radiopharmaceuticals
8.3. Therapeutic Procedures
8.3.1. Alpha Emitters
8.3.2. Beta Emitters
8.3.3. Brachytherapy Isotopes

9. Americas Radiopharmaceuticals Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Radiopharmaceuticals Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Radiopharmaceuticals Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Advanced Accelerator Applications S.A
13.2. Alliance Medical
13.3. Bayer AG
13.4. Bracco Imaging SpA
13.5. Cardinal Health, Inc.
13.6. Clarity Pharmaceuticals
13.7. Curium France SASU
13.8. Eckert & Ziegler
13.9. Eczacibasi-Monrol Nuclear Products Co.
13.10. Fusion Pharma
13.11. GE Healthcare Inc
13.12. Global Medical Solutions, LTD.
13.13. Institute of Isotopes Co., LTD.
13.14. IsoTherapeutics Group, LLC
13.15. Isotopia Molecular Imaging Limited
13.16. Joint Stock Company Isotope
13.17. Jubilant Pharma Holdings Inc.
13.18. Lantheus Medical Imaging, Inc.
13.19. Mallinckrodt PLC
13.20. Medtronic PLC
13.21. Navidea Biopharmaceuticals, Inc.
13.22. Nordion, Inc.
13.23. Northstar Medical Radioisotopes, LLC
13.24. NTP Radioisotopes Soc, LTD.
13.25. Pharmalogic
13.26. Shine Medical Technologies
13.27. Siemens Healthineers AG
13.28. Sigma- Aldrich Corporation
13.29. Sinotau Pharmaceuticals Group

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2020 (USD MILLION)
FIGURE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 6. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL RADIOPHARMACEUTICALS MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL RADIOPHARMACEUTICALS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2026
FIGURE 12. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, 2018-2026 (USD MILLION)
FIGURE 27. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 28. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 42. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 43. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2026
FIGURE 45. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2026 (USD MILLION)
FIGURE 46. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 47. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2026 (USD MILLION)
FIGURE 48. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 49. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, 2018-2026 (USD MILLION)
FIGURE 50. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 51. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, 2018-2026 (USD MILLION)
FIGURE 52. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 53. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2026 (USD MILLION)
FIGURE 54. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 55. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, 2018-2026 (USD MILLION)
FIGURE 56. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 57. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, 2018-2026 (USD MILLION)
FIGURE 58. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 59. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, 2018-2026 (USD MILLION)
FIGURE 60. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 61. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, 2018-2026 (USD MILLION)
FIGURE 62. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 63. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2026 (USD MILLION)
FIGURE 64. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 65. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, 2018-2026 (USD MILLION)
FIGURE 66. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 67. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RA-223, 2018-2026 (USD MILLION)
FIGURE 68. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RA-223, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 69. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2026 (USD MILLION)
FIGURE 70. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 71. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, 2018-2026 (USD MILLION)
FIGURE 72. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 73. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, 2018-2026 (USD MILLION)
FIGURE 74. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 75. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, 2018-2026 (USD MILLION)
FIGURE 76. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 77. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, 2018-2026 (USD MILLION)
FIGURE 78. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 79. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, 2018-2026 (USD MILLION)
FIGURE 80. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 81. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2026 (USD MILLION)
FIGURE 82. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 83. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, 2018-2026 (USD MILLION)
FIGURE 84. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 85. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, 2018-2026 (USD MILLION)
FIGURE 86. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 87. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, 2018-2026 (USD MILLION)
FIGURE 88. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 89. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, 2018-2026 (USD MILLION)
FIGURE 90. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 91. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2020 VS 2026 (%)
FIGURE 92. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2020 VS 2026 (USD MILLION)
FIGURE 93. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2026
FIGURE 94. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2026 (USD MILLION)
FIGURE 95. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 96. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2026 (USD MILLION)
FIGURE 97. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 98. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2026 (USD MILLION)
FIGURE 99. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 100. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2026 (USD MILLION)
FIGURE 101. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 102. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, 2018-2026 (USD MILLION)
FIGURE 103. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 104. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2026 (USD MILLION)
FIGURE 105. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 106. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2026 (USD MILLION)
FIGURE 107. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 108. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 109. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 110. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 111. CANADA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 112. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 113. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 114. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 115. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 116. CHINA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 117. INDIA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 118. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 119. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 120. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 121. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 122. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 123. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 124. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 125. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 126. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 127. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 128. ITALY RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 129. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 130. QATAR RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 131. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 132. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 133. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 134. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 135. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 136. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 137. GLOBAL RADIOPHARMACEUTICALS MARKET: FPNV POSITIONING MATRIX
FIGURE 138. GLOBAL RADIOPHARMACEUTICALS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 139. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RADIOPHARMACEUTICALS MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL RADIOPHARMACEUTICALS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY REGION, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY REGION, 2018-2026 (USD MILLION)
TABLE 24. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY REGION, 2018-2026 (USD MILLION)
TABLE 25. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY REGION, 2018-2026 (USD MILLION)
TABLE 27. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY REGION, 2018-2026 (USD MILLION)
TABLE 28. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY REGION, 2018-2026 (USD MILLION)
TABLE 29. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY REGION, 2018-2026 (USD MILLION)
TABLE 30. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY REGION, 2018-2026 (USD MILLION)
TABLE 31. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 32. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RA-223, BY REGION, 2018-2026 (USD MILLION)
TABLE 33. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 34. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY REGION, 2018-2026 (USD MILLION)
TABLE 35. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY REGION, 2018-2026 (USD MILLION)
TABLE 36. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY REGION, 2018-2026 (USD MILLION)
TABLE 37. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY REGION, 2018-2026 (USD MILLION)
TABLE 38. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY REGION, 2018-2026 (USD MILLION)
TABLE 39. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2018-2026 (USD MILLION)
TABLE 40. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY REGION, 2018-2026 (USD MILLION)
TABLE 41. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY REGION, 2018-2026 (USD MILLION)
TABLE 42. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY REGION, 2018-2026 (USD MILLION)
TABLE 43. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY REGION, 2018-2026 (USD MILLION)
TABLE 44. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2026 (USD MILLION)
TABLE 45. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2026 (USD MILLION)
TABLE 46. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 47. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 48. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2018-2026 (USD MILLION)
TABLE 49. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 50. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 51. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2018-2026 (USD MILLION)
TABLE 52. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 54. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 55. CANADA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 56. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 57. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 58. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 59. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 60. CHINA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 61. INDIA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 62. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 63. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 64. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 65. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 66. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 67. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 68. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 70. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 71. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 72. ITALY RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 73. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 74. QATAR RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 75. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 76. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 77. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 78. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 79. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 80. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 81. GLOBAL RADIOPHARMACEUTICALS MARKET: SCORES
TABLE 82. GLOBAL RADIOPHARMACEUTICALS MARKET: BUSINESS STRATEGY
TABLE 83. GLOBAL RADIOPHARMACEUTICALS MARKET: PRODUCT SATISFACTION
TABLE 84. GLOBAL RADIOPHARMACEUTICALS MARKET: RANKING
TABLE 85. GLOBAL RADIOPHARMACEUTICALS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 86. GLOBAL RADIOPHARMACEUTICALS MARKET: MERGER & ACQUISITION
TABLE 87. GLOBAL RADIOPHARMACEUTICALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 88. GLOBAL RADIOPHARMACEUTICALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 89. GLOBAL RADIOPHARMACEUTICALS MARKET: INVESTMENT & FUNDING
TABLE 90. GLOBAL RADIOPHARMACEUTICALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 91. GLOBAL RADIOPHARMACEUTICALS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Advanced Accelerator Applications S.A
  • Alliance Medical
  • Bayer AG
  • Bracco Imaging SpA
  • Cardinal Health, Inc.
  • Clarity Pharmaceuticals
  • Curium France SASU
  • Eckert & Ziegler
  • Eczacibasi-Monrol Nuclear Products Co.
  • Fusion Pharma
  • GE Healthcare Inc
  • Global Medical Solutions, LTD.
  • Institute of Isotopes Co., LTD.
  • IsoTherapeutics Group, LLC
  • Isotopia Molecular Imaging Limited
  • Joint Stock Company Isotope
  • Jubilant Pharma Holdings Inc.
  • Lantheus Medical Imaging, Inc.
  • Mallinckrodt PLC
  • Medtronic PLC
  • Navidea Biopharmaceuticals, Inc.
  • Nordion, Inc.
  • Northstar Medical Radioisotopes, LLC
  • NTP Radioisotopes Soc, LTD.
  • Pharmalogic
  • Shine Medical Technologies
  • Siemens Healthineers AG
  • Sigma- Aldrich Corporation
  • Sinotau Pharmaceuticals Group
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll